PharmaTimes https://pharmatimes.com in-depth news, features and insights for the pharmaceutical and healthcare sectors Thu, 02 Apr 2026 09:06:58 +0000 en-US hourly 1 https://pharmatimes.com/wp-content/uploads/2023/11/PT-icon-150x150.png PharmaTimes https://pharmatimes.com 32 32 232894315 Dale Gordon https://pharmatimes.com/appointments/dale-gordon/ Thu, 02 Apr 2026 09:06:31 +0000 https://pharmatimes.com/?p=104431 Abselion has appointed Dale Gordon as Chair of the Board of Directors

]]> 104431 Talking the talk https://pharmatimes.com/thought_leadership/talking-the-talk-2/ Thu, 02 Apr 2026 08:56:30 +0000 https://pharmatimes.com/?p=104428 It’s the start of a beautiful friendship, as Jess takes to the page

]]> 104428 FDA approves new high dose Spinraza regimen for SMA https://pharmatimes.com/news/fda-approves-new-high-dose-spinraza-regimen-for-sma/ Wed, 01 Apr 2026 13:19:37 +0000 https://pharmatimes.com/?p=104411 Updated dosing offers meaningful clinical benefit

]]> 104411 Viridian reports positive results from elegrobart phase 3 trial https://pharmatimes.com/news/viridian-reports-positive-results-from-elegrobart-phase-3-trial/ Wed, 01 Apr 2026 13:12:41 +0000 https://pharmatimes.com/?p=104409 Company says treatment shows strong efficacy and convenient dosing profile

]]> 104409 Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call https://pharmatimes.com/news/cure-parkinsons-convenes-expert-panel-to-assess-2-million-combination-therapy-funding-call/ Tue, 31 Mar 2026 12:28:31 +0000 https://pharmatimes.com/?p=104400 Specialist group to review preclinical and clinical proposals ahead of funding decision

]]> 104400 Kygevvi approved in Europe as first treatment for TK2d https://pharmatimes.com/news/kygevvi-approved-in-europe-as-first-treatment-for-tk2d/ Tue, 31 Mar 2026 12:22:35 +0000 https://pharmatimes.com/?p=104398 European Commission authorises therapy for children and adults with early‑onset disease

]]> 104398 Tozorakimab shows significant benefit in two major COPD trials https://pharmatimes.com/news/tozorakimab-shows-significant-benefit-in-two-major-copd-trials/ Mon, 30 Mar 2026 09:40:06 +0000 https://pharmatimes.com/?p=104396 Phase 3 studies report meaningful reductions in exacerbations across broad patient groups

]]> 104396 Daratumumab becomes first oncology injectable approved for patient administration https://pharmatimes.com/news/daratumumab-becomes-first-oncology-injectable-approved-for-patient-administration/ Mon, 30 Mar 2026 09:27:58 +0000 https://pharmatimes.com/?p=104394 CHMP decision allows self‑administration from phase 5 for people with multiple myeloma

]]> 104394 Laigo Bio completes final close of €17m seed financing round https://pharmatimes.com/news/laigo-bio-completes-final-close-of-e17m-seed-financing-round/ Thu, 26 Mar 2026 09:44:17 +0000 https://pharmatimes.com/?p=104387 Laigo Bio has completed the second close of its seed financing round at €5.5m, bringing the total raised to €17m

]]> 104387 AEON Biopharma appoints John Bencich as CFO https://pharmatimes.com/appointments/aeon-biopharma-appoints-john-bencich-as-cfo/ Thu, 26 Mar 2026 09:40:00 +0000 https://pharmatimes.com/?p=104384 AEON Biopharma, a biopharmaceutical company, has appointed John Bencich as Chief Financial Officer (CFO)

]]> 104384